# Ovid Therapeutics Inc.: filings

OVID · Nasdaq · CIK 1636651 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/ovid.md) · [Financials](/companies/ovid/financials.md) · [Filings](/companies/ovid/filings.md) · [Insiders](/companies/ovid/insiders.md)

## Reports and events: 199 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 154, 8-K 137, SC 13G/A 30, 10-Q 29, 3 20, SC 13G 16, 424B5 12, SCHEDULE 13G/A 12, DEF 14A 10, 10-K 9, DEFA14A 9, S-8 9, SCHEDULE 13G 8, CORRESP 7, EFFECT 6, S-3 5, 4/A 4, ARS 4, S-1/A 4, SC 13D/A 4, UPLOAD 4, 8-K/A 3, CT ORDER 3, D 3, 144 2, 424B3 2, PRE 14A 2, 10-K/A 1, 424B4 1, 8-A12B 1, CERTNAS 1, DRS 1, DRS/A 1, DRSLTR 1, PREM14A 1, S-1 1, S-8 POS 1, SC 13D 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-08-13 | 08:33 ET | [10-Q](/filings/0001628280-26-056498.md) | Quarterly report, period 2026-06-30 | 0001628280-26-056498 |
| 2026-08-13 | 08:32 ET | [8-K](/filings/0001628280-26-056497.md) | 9.01 Financial statements and exhibits | 0001628280-26-056497 |
| 2026-07-08 | 07:03 ET | [8-K](/filings/0001628280-26-047584.md) | 5.02 Departure or appointment of officers or directors | 0001628280-26-047584 |
| 2026-06-11 | 09:03 ET | [8-K](/filings/0001628280-26-042396.md) | 5.07 Shareholder vote results | 0001628280-26-042396 |
| 2026-06-03 | 07:03 ET | [8-K](/filings/0001628280-26-040038.md) | 5.02 Departure or appointment of officers or directors | 0001628280-26-040038 |
| 2026-05-12 | 07:06 ET | [10-Q](/filings/0001628280-26-033864.md) | Quarterly report, period 2026-03-31 | 0001628280-26-033864 |
| 2026-05-12 | 07:04 ET | [8-K](/filings/0001628280-26-033859.md) | 9.01 Financial statements and exhibits | 0001628280-26-033859 |
| 2026-04-27 | 17:11 ET | [DEF 14A](/filings/0001628280-26-027621.md) | Proxy statement, period 2025-12-31 | 0001628280-26-027621 |
| 2026-04-20 | 08:16 ET | [8-K](/filings/0001628280-26-025926.md) | 8.01 Other events | 0001628280-26-025926 |
| 2026-03-18 | 16:25 ET | [10-K](/filings/0001628280-26-019438.md) | Annual report, period 2025-12-31 | 0001628280-26-019438 |
| 2026-03-18 | 07:38 ET | [8-K](/filings/0001628280-26-019045.md) | 1.01 Entry into a material agreement; 2.02 Results of operations; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001628280-26-019045 |
| 2025-12-18 | 08:39 ET | [8-K](/filings/0001193125-25-323798.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-323798 |
| 2025-12-11 | 13:58 ET | [8-K](/filings/0001636651-25-000017.md) | 5.07 Shareholder vote results | 0001636651-25-000017 |
| 2025-11-12 | 07:04 ET | [10-Q](/filings/0001636651-25-000012.md) | Quarterly report, period 2025-09-30 | 0001636651-25-000012 |
| 2025-11-12 | 07:02 ET | [8-K](/filings/0001636651-25-000011.md) | 2.02 Results of operations; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001636651-25-000011 |
| 2025-11-07 | 06:06 ET | [DEF 14A](/filings/0001140361-25-040884.md) | Proxy statement, period 2025-12-11 | 0001140361-25-040884 |
| 2025-10-03 | 17:09 ET | [8-K](/filings/0001193125-25-230409.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 5.03 Amendment to articles or bylaws; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-230409 |
| 2025-09-16 | 08:00 ET | [8-K](/filings/0001193125-25-204308.md) | 8.01 Other events | 0001193125-25-204308 |
| 2025-08-13 | 08:03 ET | [10-Q](/filings/0001628280-25-040008.md) | Quarterly report, period 2025-06-30 | 0001628280-25-040008 |
| 2025-08-13 | 08:02 ET | [8-K](/filings/0001628280-25-040007.md) | 9.01 Financial statements and exhibits | 0001628280-25-040007 |
| 2025-07-10 | 16:29 ET | [8-K](/filings/0001628280-25-034733.md) | 5.07 Shareholder vote results | 0001628280-25-034733 |
| 2025-06-25 | 08:22 ET | [8-K](/filings/0001628280-25-032959.md) | 8.01 Other events | 0001628280-25-032959 |
| 2025-05-22 | 08:04 ET | [DEF 14A](/filings/0001628280-25-027146.md) | Proxy statement, period 2024-12-31 | 0001628280-25-027146 |
| 2025-05-13 | 08:08 ET | [10-Q](/filings/0001628280-25-024913.md) | Quarterly report, period 2025-03-31 | 0001628280-25-024913 |
| 2025-05-13 | 08:06 ET | [8-K](/filings/0001628280-25-024911.md) | 2.02 Results of operations | 0001628280-25-024911 |
| 2025-05-02 | 16:14 ET | [8-K](/filings/0001193125-25-111633.md) | 5.08 Item not in the standard list | 0001193125-25-111633 |
| 2025-04-30 | 16:06 ET | [10-K/A](/filings/0001628280-25-021055.md) | Annual report, amended, period 2024-12-31 | 0001628280-25-021055 |
| 2025-03-11 | 09:08 ET | [10-K](/filings/0001628280-25-011844.md) | Annual report, period 2024-12-31 | 0001628280-25-011844 |
| 2025-03-11 | 08:51 ET | [8-K](/filings/0001628280-25-011839.md) | 2.02 Results of operations | 0001628280-25-011839 |
| 2025-03-05 | 16:08 ET | [8-K](/filings/0001193125-25-047174.md) | 5.02 Departure or appointment of officers or directors | 0001193125-25-047174 |
| 2025-02-13 | 17:15 ET | [8-K](/filings/0001193125-25-026192.md) | 3.01 Delisting notice | 0001193125-25-026192 |
| 2024-11-12 | 08:07 ET | [10-Q](/filings/0001628280-24-046868.md) | Quarterly report, period 2024-09-30 | 0001628280-24-046868 |
| 2024-11-12 | 08:03 ET | [8-K](/filings/0001628280-24-046867.md) | 9.01 Financial statements and exhibits | 0001628280-24-046867 |
| 2024-09-11 | 16:57 ET | [8-K](/filings/0001193125-24-217302.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-24-217302 |
| 2024-08-13 | 08:03 ET | [10-Q](/filings/0001628280-24-036860.md) | Quarterly report, period 2024-06-30 | 0001628280-24-036860 |
| 2024-08-13 | 08:02 ET | [8-K](/filings/0001628280-24-036859.md) | 9.01 Financial statements and exhibits | 0001628280-24-036859 |
| 2024-08-02 | 17:22 ET | [8-K](/filings/0001628280-24-034481.md) | 5.02 Departure or appointment of officers or directors | 0001628280-24-034481 |
| 2024-07-01 | 08:04 ET | [8-K](/filings/0001628280-24-030546.md) | 8.01 Other events | 0001628280-24-030546 |
| 2024-06-28 | 16:02 ET | [8-K](/filings/0001193125-24-172225.md) | 2.05 Exit or disposal costs; 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure | 0001193125-24-172225 |
| 2024-06-17 | 07:10 ET | [8-K](/filings/0000950170-24-073998.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-24-073998 |
| 2024-06-07 | 16:22 ET | [8-K](/filings/0000950170-24-070673.md) | 5.07 Shareholder vote results | 0000950170-24-070673 |
| 2024-05-14 | 08:11 ET | [10-Q](/filings/0001628280-24-023067.md) | Quarterly report, period 2024-03-31 | 0001628280-24-023067 |
| 2024-05-14 | 08:03 ET | [8-K](/filings/0001628280-24-023064.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-24-023064 |
| 2024-04-24 | 16:57 ET | [DEF 14A](/filings/0000950170-24-047673.md) | Proxy statement, period 2024-04-24 | 0000950170-24-047673 |
| 2024-03-08 | 08:24 ET | [10-K](/filings/0001628280-24-009809.md) | Annual report, period 2023-12-31 | 0001628280-24-009809 |
| 2024-03-08 | 08:20 ET | [8-K](/filings/0001628280-24-009807.md) | 2.02 Results of operations | 0001628280-24-009807 |
| 2023-12-06 | 17:08 ET | [8-K](/filings/0000950170-23-068591.md) | 8.01 Other events | 0000950170-23-068591 |
| 2023-11-03 | 08:13 ET | [10-Q](/filings/0001628280-23-036564.md) | Quarterly report, period 2023-09-30 | 0001628280-23-036564 |
| 2023-11-03 | 08:10 ET | [8-K](/filings/0001628280-23-036563.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-23-036563 |
| 2023-10-18 | 08:04 ET | [8-K](/filings/0000950170-23-053875.md) | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-23-053875 |

Page 1 of 4. [Older](/companies/ovid/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:14 ET. No prices; not investment advice.